Gina Jiménez is a health reporter and The Transmitter’s former news reporting intern. She has written for Kaiser Health News, Scientific American and Slate, among other publications. She holds an M.A. in journalism from New York University’s Science, Health and Environmental Reporting Program. See more of her work at https://www.gina-jimenez.com.
Gina Jiménez
Former news reporting intern
The Transmitter
From this contributor
Martín Giurfa y la idea de hogar
El investigador de la cognición de insectos ha hecho su trabajo en varios continentes, pero Argentina nunca está lejos de su mente.
Martin Giurfa’s concept of home
The insect-cognition researcher has done his work across continents, but Argentina is never far from his mind.
Cannabis may be rescheduled–what does it mean for neuroscience?
The drug could become much easier to access, increasing the number of researchers who can work with it and the manufacturers who can produce it.
Cannabis may be rescheduled–what does it mean for neuroscience?
By
Gina Jiménez
22 May 2024 | 5 min read
How to use race and ethnicity data responsibly in neuroscience research
Follow these four tips to avoid using the information in problematic ways, including as a proxy for environmental variables.
How to use race and ethnicity data responsibly in neuroscience research
By
Gina Jiménez
24 April 2024 | 6 min read
Reporting bias widespread in early-childhood autism intervention trials
Only 7 percent of completed registered trials were later updated with results, one of several failings identified in a new analysis.
Reporting bias widespread in early-childhood autism intervention trials
By
Gina Jiménez
18 April 2024 | 5 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read